Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.1.1.11 (
seryl-tRNA synthetase
)
207
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a recent genetic screen, we identified mutations in genes important for vascular development and maintenance in zebrafish (Jin et al. Dev Biol. 2007;307:29-42). Mutations [corrected] at the adrasteia (adr) locus cause a pronounced dilatation of the aortic arch vessels as well as aberrant patterning of the hindbrain capillaries and, to a lesser extent, intersomitic vessels. This dilatation of the aortic arch vessels does not appear to be caused by increased cell proliferation but is dependent on
vascular endothelial growth factor
(Vegf) signaling. By positional cloning, we isolated
seryl-tRNA synthetase
(sars) as the gene affected by the adr mutations. Small interfering RNA knockdown experiments in human umbilical vein endothelial cell cultures indicate that SARS also regulates endothelial sprouting. These analyses of zebrafish and human endothelial cells reveal a new noncanonical function of Sars in endothelial development.
...
PMID:Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development. 1942 47
As miR-1 and miR-206 share identical seed sequences, they are commonly speculated to target the same gene. Here, we identify an mRNA encoding
seryl-tRNA synthetase
(SARS), which is targeted by miR-1, but refractory to miR-206. SARS is increased in miR-1-knockdown embryos, but it remains unchanged in the miR-206 knockdown. Either miR-1 knockdown or sars overexpression results in a failure to develop some blood vessels and a decrease in
vascular endothelial growth factor
Aa (VegfAa) expression. In contrast, sars knockdown leads to an increase of VegfAa expression and abnormal branching of vessels, similar to the phenotypes of vegfaa-overexpressed embryos, suggesting that miR-1 induces angiogenesis by repressing SARS. Unlike the few endothelial cells observed in the miR-1-knockdown embryos, knockdown of miR-206 leads to abnormal branching of vessels accompanied by an increase in endothelial cells and VegfAa. Therefore, we propose that miR-1 and miR-206 target different genes and thus have opposing roles during embryonic angiogenesis in zebrafish.
...
PMID:MiR-1 and miR-206 target different genes to have opposing roles during angiogenesis in zebrafish embryos. 2426 97
Recent studies suggested an essential role for
seryl-tRNA synthetase
(
SerRS
) in vascular development. This role is specific to
SerRS
among all tRNA synthetases and is independent of its well-known aminoacylation function in protein synthesis. A unique nucleus-directing domain, added at the invertebrate-to-vertebrate transition, confers this novel non-translational activity of
SerRS
. Previous studies showed that
SerRS
, in some unknown way, controls
VEGFA
expression to prevent vascular over-expansion. Using in vitro, cell and animal experiments, we show here that
SerRS
intervenes by antagonizing c-Myc, the major transcription factor promoting
VEGFA
expression, through a tandem mechanism. First, by direct head-to-head competition, nuclear-localized
SerRS
blocks c-Myc from binding to the
VEGFA
promoter. Second, DNA-bound
SerRS
recruits the SIRT2 histone deacetylase to erase prior c-Myc-promoted histone acetylation. Thus, vertebrate
SerRS
and c-Myc is a pair of 'Yin-Yang' transcriptional regulator for proper development of a functional vasculature. Our results also discover an anti-angiogenic activity for SIRT2.DOI: http://dx.doi.org/10.7554/eLife.02349.001.
...
PMID:tRNA synthetase counteracts c-Myc to develop functional vasculature. 2494